Actively Recruiting
Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
Led by University of Illinois at Chicago · Updated on 2024-09-20
24
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Approximately 50% of people with multiple sclerosis (MS) use a wheelchair within 30 years of the initial diagnosis. Wheelchair use in MS is often associated with fatigue as a consequence of muscle weakness. Indeed, fatigue, a prevalent consequence of MS, often becomes debilitating and exhausts energetic resources when carrying-out tasks of daily life and/or interacting with the community, as these require ambulatory mobility. This experience of excessive fatigue has its roots in muscle weakness and results in reliance on a wheelchair for mobility, and the dependency on a wheelchair may further reduce muscular strength, particularly of the lower extremities. We propose that wheelchair users with MS can increase muscular strength through a personalized exercise rehabilitation, and this in turn will improve ambulatory performance and possibly reduce fatigue. To date, no research has examined the effects of this specific exercise rehabilitation program (GH method) on physical function and other disease-related outcomes in persons with MS who use wheelchairs as a primary mobility device.
CONDITIONS
Official Title
Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of multiple sclerosis
- Age above 18 years
- No relapse within the last 30 days
- Use wheelchair for mobility in the community
- Able to walk at least 50 feet or 65 steps using an assistive device
- Low risk for physical activity contraindications with no more than one "yes" on the Physical Activity Readiness Questionnaire (PAR-Q)
- Willingness to complete assessments and undergo randomization
You will not qualify if you...
- No diagnosis of multiple sclerosis
- Under 18 years of age
- Had a relapse within the last 30 days
- Do not use a wheelchair as primary mobility device
- Unable to walk at least 50 feet or 65 steps
- High risk for physical activity contraindications with more than one "yes" on the PAR-Q
- Not willing to complete testing procedures or undergo randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
E
Enrico Benedetti, MD
CONTACT
I
Ilaria Santi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here